Guggenheim Securities

Oracle Corp (NYSE: ORCL) shares traded higher on Tuesday, after the Austin, Texas-based company reported its fiscal second-quarter results. Piper Sandler analyst Brent Bracelin maintained a Neutral rating, while raising the price target from $75 to $85. JMP Securities analyst Patrick Walravens...

Ulta Beauty Inc (NASDAQ: ULTA) raised its outlook and beat analyst expectations for quarterly earnings and sales as consumers continue to restock their makeup bags despite paying more for products. The cosmetics company paid $5.34 per share, on revenues of $2.34 billion, ahead of the expected $4.15...

Zscaler Inc.’s (NASDAQ: ZS) shares traded higher in the after-hours session on Thursday, following the company’s fiscal first-quarter print. Zscaler reported revenues of $355.55 million and earnings of 29 cents per share, with both matrices topping consensus estimates. Stephens On...

Shares of Foot Locker, Inc. (NYSE: FL) climbed on Friday, after the company reported better-than-expected earnings for the second quarter and announced that former CEO of Ulta Beauty Inc (NASDAQ: ULTA) Mary N. Dillon will replace its current CEO, effective September 1, 2022. Guggenheim Securities...

A day after Square Inc (NYSE: SQ) reported its fourth-quarter results and announced the purchase of $170 million worth of Bitcoin (CRYPTO: BTC), an analyst at Guggenheim Securities upgraded the shares of the payment processor. The Square Analyst: Jeff Cantwell upgraded Square shares from Neutral...

As part of its outlook for biopharma companies in 2021, Guggenheim Securities turned bullish on Amneal Pharmaceuticals Inc (NYSE: AMRX). The Amneal Analyst: Dana Flanders upgraded Amneal from Neutral to Buy with a $5.50 price target.  The Amneal Thesis: Revenue and margin...

An analyst at Guggenheim Securities turned bullish on pharma giant Bristol-Myers Squibb Co (NYSE: BMY) Monday, basing their optimism on a revival in sales of its flagship immuno-oncology drug Opdivo. The Bristol-Myers Squibb Analyst:  Analyst Seamus Fernandez upgraded Bristol-Myers Squibb...

Arvinas Inc (NASDAQ: ARVN) shares have been on a tear ever since the company issued a platform update in late October. The Analyst Guggenheim Securities analyst Michael Schmidt initiated coverage of Arvinas with a Buy rating and $50 price target.  The Thesis Arvinas, a small-cap, early...

Shares of The Western Union Company (NYSE: WU) rallied 25% after the company reported strong third-quarter earnings and hosted a positive investor day Sept. 24. While the company’s long-term revenue and earnings growth outlook have improved, its near-term prospects remain unchanged,...

Krystal Biotech Inc (NASDAQ: KRYS) announced positive Phase 2 data for KB103 Monday and said the gene therapy received the Regenerative Medicine Advanced Therapy designation from the FDA. The Phase 2 results are close to a “best-case scenario”, according to Guggenheim Securities....

PagSeguro Digital Ltd (NYSE: PAGS) announced a major product expansion Tuesday in financial services. It's a sign of the company’s rapid transformation into a full-fledged acquiring and financial services platform and significantly boosts PagSeguro's long-term top- and...

8x8, Inc. (NYSE: EGHT) reported mixed fourth-quarter results Tuesday. Although metrics are trending up, the cloud communications company has taken a conservative approach to guidance, which could keep the stock rangebound in the near term, according to Guggenheim Securities. The Analyst Nandan...

Analysts across the Street upped their valuations of Roku Inc (NASDAQ: ROKU) to accommodate a post-earnings surge. Roku reported first-quarter revenue of $206.7 million and a loss per share of 9 cents against consensus estimates of $191.97 million and 25 cents, respectively. Management also...

GreenSky Inc (NASDAQ: GSKY) reported disappointing first-quarter revenue Tuesday on softer-than-expected transaction volumes. Although the company’s underlying business momentum is good, it's already reflected in the stock following a rally year-to-date, according to Guggenheim Securities...

Fiserv Inc (NASDAQ: FISV) reported higher-than-expected first-quarter results Tuesday, with healthy internal revenue growth. The investor focus is likely to remain on the merger with First Data Corporation (NYSE: FDC) deal, and the fact that First Data reported a strong first quarter...